New research leads to FDA approval of first drug to treat radiation sickness

(University of Maryland School of Medicine) New research has led the FDA to approve use of a drug to treat the effects of radiation exposure following a nuclear incident. The drug, Neupogen, is the first ever approved for the treatment of acute radiation injury.

http://www.eurekalert.org/pub_releases/2015-05/uoms-nrl052215.php

Source: EurekAlert! - Medicine and Health - May 22, 2015 Category: Global & Universal Source Type: news

More News: Filgrastim | Health | International Medicine & Public Health | Neupogen | University of Maryland